Evidence map›Paper›PMID 38524182›Full record

ArticleFrontiers in cellular and infection microbiology2024

Characterization of a

Liming Jiang, Qian Xu, Ying Wu, Xianglian Zhou, Zhu Chen, Qiangming Sun, Jinsheng Wen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Revisiting the Fight AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Advances in phage therapy forFrontiers in microbiology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Liming Jiang *School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
Qian Xu *Department of Blood Transfusion, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China.
Ying Wu *Department of Rheumatology Immunology, The First People's Hospital of Hefei, Hefei, Anhui, China.
Xianglian Zhou *Department of Rheumatology Immunology, The First People's Hospital of Hefei, Hefei, Anhui, China.
Zhu ChenDepartment of Laboratory, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
Qiangming SunNational Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.
Jinsheng WenSchool of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
Hefei First People's Hospital · CNNingbo University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNJianghan University · CNNingbo No.6 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiBacteriophagesAnti-Bacterial AgentsBiofilmsEscherichia coliHumansAnti-Bacterial AgentsAcinetobacter baumanniiantibioticbacterial biofilminhibitionphage

Identifiers

PMID38524182
PMCPMC10958429
OpenAlexW4392596107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.